Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.89 is 51% above its 3-year average of -1.83, near the high end of its 3-year range (-3.26–-0.89).
58.80% above its 12-month average of -2.16.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.20.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 10 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.89
EARNINGS PER SHARE (EPS) AVG TTM
-2.16
EARNINGS PER SHARE (EPS) AVG 3Y
-1.83
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+58.80%
CURRENT VS 3Y AVG
+51.30%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Actuate Therapeutics Inc
Market Cap
$20.93M
Earnings Per Share (EPS)
-0.89
TTM Avg
-2.16
3Y Avg
-1.83
5Y Avg
N/A
Market Cap
$21.90M
Earnings Per Share (EPS)
-1.66
TTM Avg
-1.66
3Y Avg
-2.82
5Y Avg
-25.82
Market Cap
$18.82M
Earnings Per Share (EPS)
-0.66
TTM Avg
-0.90
3Y Avg
-9.28
5Y Avg
-9.88
Market Cap
$18.77M
Earnings Per Share (EPS)
-0.25
TTM Avg
-0.29
3Y Avg
-0.28
5Y Avg
-0.20
Market Cap
$24.44M
Earnings Per Share (EPS)
-4.34
TTM Avg
-3.52
3Y Avg
-3.45
5Y Avg
-7.67
Market Cap
$16.58M
Earnings Per Share (EPS)
-3.73
TTM Avg
-46.49
3Y Avg
-194.14
5Y Avg
-195.03
Market Cap
$16.54M
Earnings Per Share (EPS)
-0.21
TTM Avg
-0.22
3Y Avg
-0.25
5Y Avg
-0.30
Market Cap
$25.48M
Earnings Per Share (EPS)
-0.29
TTM Avg
-0.41
3Y Avg
-1.95
5Y Avg
-2.99
Market Cap
$16.22M
Earnings Per Share (EPS)
-0.76
TTM Avg
-2.06
3Y Avg
-5.59
5Y Avg
-9.29
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Actuate Therapeutics Inc (ACTU) | $20.93M | -0.89 | -2.16 | -1.83 | N/A |
| Aytu BioPharma, Inc. (AYTU)vs › | $21.90M | -1.66 | -1.66 | -2.82 | -25.82 |
| Cosmos Health Inc. (COSM)vs › | $18.82M | -0.66 | -0.90 | -9.28 | -9.88 |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | -0.25 | -0.29 | -0.28 | -0.20 |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | -4.34 | -3.52 | -3.45 | -7.67 |
| Bionano Genomics, Inc. (BNGO)vs › | $16.58M | -3.73 | -46.49 | -194.14 | -195.03 |
| Dyadic International, Inc. (DYAI)vs › | $16.54M | -0.21 | -0.22 | -0.25 | -0.30 |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.48M | -0.29 | -0.41 | -1.95 | -2.99 |
| BioCardia, Inc. (BCDA)vs › | $16.22M | -0.76 | -2.06 | -5.59 | -9.29 |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.91M | -0.78 | -8.29 | -9461.74 | -302593.36 |
Trailing EPS (TTM)
$-0.89
Forward EPS (Est.)
$-0.73
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.06 |
| 2024-12-31 | -3.26 |
| 2023-12-31 | -1.65 |
| 2022-12-31 | -1.34 |
